Hetero Labs Limited Valsartan Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Valsartan Export Records India — #11 Exporter, 75 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Valsartan

India Pharmaceutical Trade Intelligence

$196.9M259 Suppliers119 CountriesHS 30049079

ExportsIndia → UNITED STATES60.8%India → GERMANY6.2%

ImportsITALY → India$280.6B BULGARIA → India$7.2M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Hetero Labs Limited — Valsartan Exporter #11 | $2.3M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Valsartan Exporter Profile

Indian Pharmaceutical Exporter · #11 for Valsartan · $2.3M export value · DGFT Verified

Hetero Labs Limited is the #11 Indian exporter of Valsartan with $2.3M in export value and 75 verified shipments. Hetero Labs Limited holds a 1.2% market share in Valsartan exports across 18 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Valsartan Export Profile: Buyers & Destinations

Hetero Labs Limited Valsartan export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Valsartan?

Country	Value	Shipments	Share
EL SALVADOR	$272.3K	6	23.9%
UNITED STATES OF AMERICA	$250.0K	5	22.0%
SAUDI ARABIA	$150.0K	3	13.2%
CHILE	$114.0K	5	10.0%
MEXICO	$91.5K	7	8.0%

Who Are the Top Buyers of Valsartan from Hetero Labs Limited?

Buyer	Country	Value	Orders
XXVENXXHARXX ELXXALVXXOR XXA XX C XX	EL SALVADOR	$272.3K	6
XXMBEXXPHAXXACEXXICAXX IXX	UNITED STATES OF AMERICA	$250.0K	5
SAUDI AMAROX FOR INDUSTRY COMPANY	SAUDI ARABIA	$150.0K	3
TO THE ORDER OF.	ZAMBIA	$140.4K	11
SEVEN PHARMA HONDURAS S.A.COL. MIRA	HONDURAS	$61.2K	3
SEVEN PHARMA CHILE SPA	CHILE	$58.1K	3
XXTERXXFZCX	CHILE	$55.9K	2
XXAROXXPHAXXA SXX DXXC VX	MEXICO	$47.4K	4
XXAROXXPHAXXA XXA XX C XX	MEXICO	$44.1K	3
TO THE ORDER OF	BRAZIL	$40.1K	24

Hetero Labs Limited supplies Valsartan to 16 buyers globally. The largest buyer is XXVENXXHARXX ELXXALVXXOR XXA XX C XX (EL SALVADOR), followed by XXMBEXXPHAXXACEXXICAXX IXX (UNITED STATES OF AMERICA) and SAUDI AMAROX FOR INDUSTRY COMPANY (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Valsartan Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
VALSARTAN 320MG TABLETS (3X10'S)	$250.0K	5
VALSARTAN 320MG TABLETS	$172.3K	4
VALSARTAN 320MG TABLETS (1X90'S)	$100.0K	2
VALSARTAN 80MG TABLETS (1X30'S)	$70.0K	6
SACUBITRIL+VALSARTAN TABLET	$57.8K	3
SACVALY 24 26 SACUBITRIL VALSARTAN 24MG 26MG TABLET 10S	$50.0K	1
SACVALY 97 103 SACUBITRIL VALSARTAN 97MG 103MG TABLET 10S	$50.0K	1
SACVALY 49 51 SACUBITRIL VALSARTAN 49MG 51MG TABLET 10S	$50.0K	1
VALSARTAN 80MG TABLETS	$47.5K	2
SACUBITRIL+VALSARTAN TABLET (FREE UNITS-10440 TABLET)	$33.7K	1

Hetero Labs Limited exports 54 distinct Valsartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VALSARTAN 320MG TABLETS (3X10'S) with 5 shipments worth $250.0K.

How Does Hetero Labs Limited Compare to Nearest Valsartan Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	JUBILANT GENERICS LIMITED	$4.2M	85	7	$49.4K
10	ALKEM LABORATORIES LIMITED	$2.5M	49	1	$50.0K
11	HETERO LABS LIMITED ★	$2.3M	75	18	$30.6K
12	TORRENT PHARMACEUTICALS LTD	$1.5M	65	4	$23.3K
13	ZYDUS LIFESCIENCES LIMITED	$1.4M	64	7	$21.7K

Hetero Labs Limited ranks #11 among 259 Indian Valsartan exporters. Average shipment value of $30.6K compared to the market average of $438.5K. The closest competitors by value are JUBILANT GENERICS LIMITED and ALKEM LABORATORIES LIMITED.

Which Indian Ports Ship Valsartan Exports?

Port	Shipments	% Share
SAHAR AIR	946	15.5%
SAHAR AIR CARGO ACC (INBOM4)	707	11.6%
DELHI AIR CARGO ACC (INDEL4)	627	10.3%
DELHI AIR	516	8.5%
NHAVA SHEVA SEA (INNSA1)	445	7.3%
JNPT/ NHAVA SHEVA SEA	323	5.3%
JNPT	213	3.5%
MUNDRA SEA	176	2.9%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Valsartan Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 75 individual customs records matching Hetero Labs Limited exporting Valsartan, covering 54 formulations to 18 countries via 16 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 663+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Valsartan

Valsartan

Hetero Labs Limited — Valsartan Exporter Profile

Hetero Labs Limited — Valsartan Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Valsartan?

Who Are the Top Buyers of Valsartan from Hetero Labs Limited?

What Is India's Total Valsartan Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Valsartan Exports?

How Does Hetero Labs Limited Compare to Other Indian Valsartan Exporters?

What Valsartan Formulations Does Hetero Labs Limited Export?

How Does Hetero Labs Limited Compare to Nearest Valsartan Exporters?

Which Indian Ports Ship Valsartan Exports?

What Other Cardiovascular Products Does Hetero Labs Limited Export?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Valsartan Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Valsartan Export Data from Hetero Labs Limited

Valsartan Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source